Literature DB >> 25398103

Sepsis biomarkers. Value and limitations.

Jean-Louis Vincent1, Larissa Teixeira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25398103     DOI： 10.1164/rccm.201410-1895ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  Immunology. Getting sepsis therapy right.

Authors:  Richard S Hotchkiss; Edward R Sherwood
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 2.  How nanotechnology-enabled concepts could contribute to the prevention, diagnosis and therapy of bacterial infections.

Authors:  Inge K Herrmann
Journal:  Crit Care       Date:  2015-05-29       Impact factor: 9.097

Review 3.  A Pathophysiological Insight into Sepsis and Its Correlation with Postmortem Diagnosis.

Authors:  C Pomara; I Riezzo; S Bello; D De Carlo; M Neri; E Turillazzi
Journal:  Mediators Inflamm       Date:  2016-04-27       Impact factor: 4.711

4.  Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology.

Authors:  Ebrahim Salehifar; Shima Tavakolian Arjmand; Masoud Aliyali; Siavash Abedi; Ali Sharifpour; Abbas Alipour; Shahram Ala; Gohar Eslami; Farzad Bozorgi; Mohammad Reza Mahdavi; Keith R Walley
Journal:  Tanaffos       Date:  2016

5.  Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study.

Authors:  Sm Gowri Vishalashi; Poonam Gupta; Pardeep Kumar Verma
Journal:  Indian J Crit Care Med       Date:  2021-05

6.  Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit.

Authors:  Monica Garcia-Simon; Jose M Morales; Vicente Modesto-Alapont; Vannina Gonzalez-Marrachelli; Rosa Vento-Rehues; Angela Jorda-Miñana; Jose Blanquer-Olivas; Daniel Monleon
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

7.  Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections.

Authors:  Jean-Louis Vincent; David Brealey; Nicolas Libert; Nour Elhouda Abidi; Michael O'Dwyer; Kai Zacharowski; Malgorzata Mikaszewska-Sokolewicz; Jacques Schrenzel; François Simon; Mark Wilks; Marcus Picard-Maureau; Donald B Chalfin; David J Ecker; Rangarajan Sampath; Mervyn Singer
Journal:  Crit Care Med       Date:  2015-11       Impact factor: 7.598

8.  Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Catarina Chaves; Marisa Caetano; Luís Almeida; José Artur Paiva
Journal:  Burns Trauma       Date:  2018-03-31

9.  Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Margarida Marques; Isabel Tourais; Catarina Chaves; Luís Almeida; José Artur Paiva
Journal:  BMC Anesthesiol       Date:  2018-09-05       Impact factor: 2.217

10.  Visfatin Serum Levels Predict Mortality in Critically Ill Patients.

Authors:  Alexander Koch; Ralf Weiskirchen; Alexander Krusch; Jan Bruensing; Lukas Buendgens; Ulf Herbers; Eray Yagmur; Ger H Koek; Christian Trautwein; Frank Tacke
Journal:  Dis Markers       Date:  2018-08-26       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.